A peroxisome proliferator-activated receptor-alpha activator induces renal CYP2C23 activity and protects from angiotensin II-induced renal injury (Q38584663)

From Wikidata

Jump to navigation Jump to search

scientific article published on February 2004

Language	Label	Description	Also known as
English	A peroxisome proliferator-activated receptor-alpha activator induces renal CYP2C23 activity and protects from angiotensin II-induced renal injury	scientific article published on February 2004

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

4 September 2017

A peroxisome proliferator-activated receptor-alpha activator induces renal CYP2C23 activity and protects from angiotensin II-induced renal injury (English)

1 reference

Europe PubMed Central

PMC publication ID

4 September 2017

Anette Fiebeler

12

object named as

Anette Fiebeler

1 reference

Europe PubMed Central

PMC publication ID

4 September 2017

9

object named as

Ralf Dechend

1 reference

Europe PubMed Central

PMC publication ID

4 September 2017

15

object named as

Friedrich C Luft

1 reference

Europe PubMed Central

PMC publication ID

4 September 2017

Erdenechimeg Shagdarsuren

3

object named as

Erdenechimeg Shagdarsuren

1 reference

Europe PubMed Central

4 September 2017

PMC publication ID

14

object named as

Hermann Haller

1 reference

Europe PubMed Central

PMC publication ID

4 September 2017

Dominik N. Muller

1

object named as

Dominik N Muller

1 reference

Europe PubMed Central

PMC publication ID

4 September 2017

10

object named as

Maren Wellner

1 reference

Europe PubMed Central

PMC publication ID

4 September 2017

2

object named as

Juergen Theuer

1 reference

Europe PubMed Central

PMC publication ID

4 September 2017

6

object named as

Joon-Keun Park

1 reference

Europe PubMed Central

PMC publication ID

4 September 2017

4

object named as

Eva Kaergel

1 reference

Europe PubMed Central

PMC publication ID

4 September 2017

5

object named as

Horst Honeck

1 reference

Europe PubMed Central

PMC publication ID

4 September 2017

Wolf-Hagen Schunck

16

object named as

Wolf-Hagen Schunck

1 reference

Europe PubMed Central

PMC publication ID

4 September 2017

author name string

Marija Markovic

7

1 reference

Europe PubMed Central

PMC publication ID

4 September 2017

Eduardo Barbosa-Sicard

8

1 reference

Europe PubMed Central

PMC publication ID

4 September 2017

Torsten Kirsch

11

1 reference

Europe PubMed Central

PMC publication ID

4 September 2017

Michael Rothe

13

1 reference

Europe PubMed Central

PMC publication ID

4 September 2017

language of work or name

0 references

publication date

1 February 2004

1 reference

Europe PubMed Central

PMC publication ID

4 September 2017

The American Journal of Pathology

1 reference

Europe PubMed Central

PMC publication ID

4 September 2017

164

1 reference

Europe PubMed Central

PMC publication ID

4 September 2017

2

1 reference

Europe PubMed Central

PMC publication ID

4 September 2017

521-532

1 reference

Europe PubMed Central

PMC publication ID

4 September 2017

Lipid lowering: another method of reducing blood pressure?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1602252

6 September 2017

Immunosuppressive treatment protects against angiotensin II-induced renal damage

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1602252

6 September 2017

The CYP4A isoforms hydroxylate epoxyeicosatrienoic acids to form high affinity peroxisome proliferator-activated receptor ligands

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1602252

6 September 2017

Soluble epoxide hydrolase inhibition lowers arterial blood pressure in angiotensin II hypertension

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1602252

6 September 2017

What is new in endothelium-derived hyperpolarizing factors?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1602252

6 September 2017

P-450 metabolites of arachidonic acid in the control of cardiovascular function

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1602252

6 September 2017

Aspirin inhibits NF-kappaB and protects from angiotensin II-induced organ damage

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1602252

6 September 2017

Epoxygenase pathways of arachidonic acid metabolism

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1602252

6 September 2017

Peroxisome proliferator-activated receptors in inflammation control

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1602252

6 September 2017

CYP4A1 antisense oligonucleotide reduces mesenteric vascular reactivity and blood pressure in SHR.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1602252

6 September 2017

Eicosanoid regulation of the renal vasculature

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1602252

6 September 2017

Effects of comicronised fenofibrate on lipid and insulin sensitivity in patients with polymetabolic syndrome X.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1602252

6 September 2017

Is EDHF an epoxyeicosatrienoic acid?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1602252

6 September 2017

Cytochrome P450 and arachidonic acid bioactivation. Molecular and functional properties of the arachidonate monooxygenase

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1602252

6 September 2017

Cytochrome P450 2C is an EDHF synthase in coronary arteries

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1602252

6 September 2017

The kidney cytochrome P-450 2C23 arachidonic acid epoxygenase is upregulated during dietary salt loading.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1602252

6 September 2017

20-HETE and the kidney: resolution of old problems and new beginnings

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1602252

6 September 2017

Anti-inflammatory properties of cytochrome P450 epoxygenase-derived eicosanoids.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1602252

6 September 2017

Possible role of P-450 metabolite of arachidonic acid in vasodilator mechanism of angiotensin II type 2 receptor in the isolated microperfused rabbit afferent arteriole

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1602252

6 September 2017

Experimental and/or genetically controlled alterations of the renal microsomal cytochrome P450 epoxygenase induce hypertension in rats fed a high salt diet

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1602252

6 September 2017

Angiotensin II (AT(1)) receptor blockade reduces vascular tissue factor in angiotensin II-induced cardiac vasculopathy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1602252

27 September 2017

Role of the peroxisome proliferator-activated receptor in cytochrome P450 4A gene regulation.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1602252

27 September 2017

Activation of human aortic smooth-muscle cells is inhibited by PPARalpha but not by PPARgamma activators

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1602252

23 June 2018

Angiographic assessment of effects of bezafibrate on progression of coronary artery disease in young male postinfarction patients

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1602252

23 June 2018

Clofibrate prevents the development of hypertension in Dahl salt-sensitive rats.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1602252

23 June 2018

Relationships between low-density lipoprotein particle size, plasma lipoproteins, and progression of coronary artery disease: the Diabetes Atherosclerosis Intervention Study (DAIS).

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1602252

31 August 2018

PPARalpha activator effects on Ang II-induced vascular oxidative stress and inflammation

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1602252

31 August 2018

P450-dependent arachidonic acid metabolism and angiotensin II-induced renal damage

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1602252

31 August 2018

Cytochrome P450-dependent eicosapentaenoic acid metabolites are novel BK channel activators

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1602252

31 August 2018

Reduction in stroke with gemfibrozil in men with coronary heart disease and low HDL cholesterol: The Veterans Affairs HDL Intervention Trial (VA-HIT).

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1602252

31 August 2018

Bezafibrate reduces heart rate and blood pressure in patients with hypertriglyceridemia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1602252

31 August 2018

Cytochrome P450-dependent renal arachidonic acid metabolism in desoxycorticosterone acetate-salt hypertensive mice.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1602252

31 August 2018

Blood pressure-independent effects in rats with human renin and angiotensinogen genes.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1602252

31 August 2018

Renal P450 metabolites of arachidonic acid and the development of hypertension in Dahl salt-sensitive rats.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1602252

31 August 2018

Induction of IκBα Expression as a Mechanism Contributing to the Anti-inflammatory Activities of Peroxisome Proliferator-activated Receptor-α Activators

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1602252

3 December 2018

Fenofibrate lowers blood pressure in two genetic models of hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9440%2810%2963142-2

7 January 2021

Synthesis of epoxyeicosatrienoic acids and heteroatom analogs

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9440%2810%2963142-2

7 January 2021

Peroxisome Proliferator-activated Receptor α Negatively Regulates the Vascular Inflammatory Gene Response by Negative Cross-talk with Transcription Factors NF-κB and AP-1

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9440%2810%2963142-2

7 January 2021

Salt-sensitive hypertension after exposure to angiotensin is associated with inability to upregulate renal epoxygenases

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9440%2810%2963142-2

7 January 2021

Gene Structure and Promoter Analysis of the Rat ConstitutiveCYP2C23Gene

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9440%2810%2963142-2

7 January 2021

Proinflammatory mediators chronically downregulate the formation of the endothelium-derived hyperpolarizing factor in arteries via a nitric oxide/cyclic GMP-dependent mechanism

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9440%2810%2963142-2

7 January 2021

Endothelin-1 and CYP450 arachidonate metabolites interact to promote tissue injury in DOCA-salt hypertension

1 reference

https://pubmed.ncbi.nlm.nih.gov/14742258

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1016/S0002-9440(10)63142-2

1 reference

Europe PubMed Central

PMC publication ID

4 September 2017

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

4 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

4 September 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q38584663&oldid=2241231977"